23 OCTOBER 2018 BIOTECH DAILY
Anatara says it has appointed a product development advisory board for its non-antibiotic, pineapple stem bromelain-derived gastro-intestinal health programs.
Anatara said the board would be chaired by Prof Peter Gibson and comprise Dr Rebecca Burgell, Dr Jakob Begun, Prof Barry Campbell and Prof Simon Keely and provide advice on issues relating to research priorities, strategies and product development programs.
Anatara fell two cents or five percent to 38 cents.
To read the full article, please click here: 181023 BD Biotech Daily – PDAB Appointments